PortfoliosLab logoPortfoliosLab logo
WDNA vs. BBC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. BBC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDNA achieves a 5.85% return, which is significantly lower than BBC's 8.64% return.


WDNA

1D
1.24%
1M
-0.73%
YTD
5.85%
6M
8.14%
1Y
45.86%
3Y*
2.45%
5Y*
-5.33%
10Y*

BBC

1D
0.43%
1M
-6.52%
YTD
8.64%
6M
14.08%
1Y
116.78%
3Y*
19.99%
5Y*
-1.96%
10Y*
7.64%
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. BBC - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WDNA
WisdomTree BioRevolution Fund
5.85%22.68%-14.18%-2.07%-26.29%-5.27%
BBC
Virtus LifeSci Biotech Clinical Trials ETF
8.64%63.77%-1.11%-1.80%-35.13%-19.18%

Correlation

The correlation between WDNA and BBC is 0.80, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.80

Correlation (3Y)
Calculated over the trailing 3-year period

0.84

Correlation (5Y)
Calculated over the trailing 5-year period

0.86

Correlation (All Time)
Calculated using the full available price history since Jun 4, 2021

0.86

The correlation between WDNA and BBC has been stable across timeframes, ranging from 0.80 to 0.86 - a consistent structural relationship.

WDNA vs. BBC - Sectors Allocation Comparison


Sectors
WDNA
BBC

Healthcare

85.0%
100.0%

Basic Materials

6.5%

-

Consumer Defensive

3.0%

-

Energy

1.1%

-

Communication Services

-

-

Consumer Cyclical

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

WDNA
85.0%
BBC
100.0%

Basic Materials

WDNA
6.5%
BBC

-

Consumer Defensive

WDNA
3.0%
BBC

-

Energy

WDNA
1.1%
BBC

-

Communication Services

WDNA

-

BBC

-

Consumer Cyclical

WDNA

-

BBC

-

Financial Services

WDNA

-

BBC

-

Industrials

WDNA

-

BBC

-

Real Estate

WDNA

-

BBC

-

Technology

WDNA

-

BBC

-

Utilities

WDNA

-

BBC

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. BBC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA
WDNA Risk / Return Rank: 5757
Overall Rank
WDNA Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 5555
Sortino Ratio Rank
WDNA Omega Ratio Rank: 4848
Omega Ratio Rank
WDNA Calmar Ratio Rank: 7878
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5353
Martin Ratio Rank

BBC
BBC Risk / Return Rank: 8989
Overall Rank
BBC Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 8787
Sortino Ratio Rank
BBC Omega Ratio Rank: 7777
Omega Ratio Rank
BBC Calmar Ratio Rank: 9595
Calmar Ratio Rank
BBC Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. BBC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WDNABBCDifference
Sharpe ratioReturn per unit of total volatility

-1.51

Sortino ratioReturn per unit of downside risk

-1.33

Omega ratioGain probability vs. loss probability

1.30

1.46

-0.16

Calmar ratioReturn relative to maximum drawdown

3.94

7.78

-3.84

Martin ratioReturn relative to average drawdown

8.95

24.80

-15.85

WDNA vs. BBC - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.81, which is lower than the BBC Sharpe Ratio of 3.32. The chart below compares the historical Sharpe Ratios of WDNA and BBC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WDNABBCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.81

3.32

-1.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.21

-0.05

-0.16

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.21

0.12

-0.33

Drawdowns

WDNA vs. BBC - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for WDNA and BBC.


Loading charts...

Drawdown Indicators


WDNABBCDifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

-76.85%

+17.98%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

-15.10%

+3.40%

Max Drawdown (3Y)

Largest decline over 3 years

-38.25%

-54.45%

+16.20%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

-72.44%

+13.57%

Max Drawdown (10Y)

Largest decline over 10 years

-76.85%

Current Drawdown

Current decline from peak

-31.86%

-30.27%

-1.59%

Average Drawdown

Average peak-to-trough decline

-35.65%

-37.14%

+1.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.14%

4.73%

+0.41%

Volatility

WDNA vs. BBC - Volatility Comparison

The current volatility for WisdomTree BioRevolution Fund (WDNA) is 6.75%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that WDNA experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDNABBCDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.75%

10.93%

-4.18%

Volatility (6M)

Calculated over the trailing 6-month period

16.39%

26.43%

-10.04%

Volatility (1Y)

Calculated over the trailing 1-year period

25.53%

35.50%

-9.97%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.04%

39.31%

-14.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.04%

37.74%

-12.70%

WDNA vs. BBC - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is lower than BBC's 0.79% expense ratio.


Dividends

WDNA vs. BBC - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.31%, more than BBC's 1.56% yield.


PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF
1.56%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
WDNA
WisdomTree BioRevolution Fund
4.31%4.57%0.75%0.80%0.38%0.10%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


WDNA and BBC have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBC has higher volatility (10.93%) compared to WDNA (6.75%). In terms of maximum drawdown, WDNA dropped -58.87% vs BBC's -76.85%.

On 5-year performance, BBC leads with -1.96% vs -5.33% for WDNA. On fees, WDNA is cheaper at 0.45% per year. On volatility, WDNA has been the lower-risk option at 6.75%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, BBC has performed better with a -1.96% return vs -5.33%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

WDNA is cheaper with a 0.45% expense ratio, compared with 0.79% for BBC.

WDNA has the higher dividend yield at 4.31%, compared with 1.56% for BBC.

WDNA tracks WisdomTree BioRevolution Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: WisdomTree and Virtus Investment Partners. Their fees differ too: 0.45% for WDNA and 0.79% for BBC.

BBC currently has the higher Sharpe Ratio (3.32 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WDNA and BBC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer